AbbVie says Pharmacyclics drug, new form of Humira to lift company

March 5 (Reuters) - AbbVie Inc said on Thursday it fought two other drugmakers to "the bitter end" to buy Pharmacyclics Inc and its hot-selling Imbruvica cancer drug, and expects the medicine to generate eventual peak annual sales of more than $7 billion.